Intuitive Surgical, Inc. (ISRG)
| Market Cap | 148.77B -19.3% |
| Revenue (ttm) | 10.58B +21.4% |
| Net Income | 2.98B +20.3% |
| EPS | 8.23 +20.5% |
| Shares Out | 354.16M |
| PE Ratio | 51.05 |
| Forward PE | 39.48 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,032,993 |
| Open | 446.91 |
| Previous Close | 450.06 |
| Day's Range | 417.74 - 448.75 |
| 52-Week Range | 417.74 - 603.88 |
| Beta | 1.51 |
| Analysts | Buy |
| Price Target | 591.32 (+40.77%) |
| Earnings Date | Apr 21, 2026 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,... [Read more]
Financial Performance
In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price target is $591.32, which is an increase of 40.77% from the latest price.
News
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...
Intuitive Surgical removes 8mm SureForm 30 gray reloads, FDA reports
The FDA is aware that Intuitive Surgical (ISRG) has issued a letter to affected customers recommending all 8mm SureForm 30 gray reloads for curved-tip staplers be removed from where they…
Intuitive Surgical Transcript: AGM 2026
The meeting saw all board nominees elected and all proposals approved, including executive compensation and auditor ratification. Strong financial results were reported for 2025 and Q1 2026, with continued focus on global expansion, innovation, and manufacturing optimization amid competitive and geopolitical challenges.
Intuitive Surgical (ISRG) Beats Q1 Expectations. The Bull Case Builds
Intuitive Surgical ($ISRG) remains an attractive long-term story following another strong quarter. The Q1 results released on April 21 reinforced the durability of its growth model. The leader in mini...
The Biggest Takeaway From ISRG Earnings
The key takeaway from Intuitive Surgical's (ISRG) Q1 2026 results is the implementation of a fundamental “Platform Refresh Wall.” In addition to the $2.50 EPS exceeding expectations and a revenue grow...
Intuitive Surgical price target lowered to $651 from $712 at Barclays
Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $651 from $712 and keeps an Overweight rating on the shares post the Q1 report. The company reported a…
Intuitive Surgical price target raised to $610 from $575 at Baird
Baird raised the firm’s price target on Intuitive Surgical (ISRG) to $610 from $575 and keeps an Outperform rating on the shares. The firm updated its model following beat and…
Intuitive Surgical price target lowered to $580 from $620 at Piper Sandler
Piper Sandler analyst Adam Maeder lowered the firm’s price target on Intuitive Surgical (ISRG) to $580 from $620 and keeps an Overweight rating on the shares. The firm notes the…
Intuitive Surgical beats quarterly expectations on surgical robot demand
Intuitive Surgical on Tuesday beat Wall Street estimates for first-quarter profit and revenue, as the firm rode the wave of robust demand for its minimally invasive surgical robots used in complex m...
Intuitive Surgical says lower growth rate reflects ongoing China/Japan challenge
In its Q1 conference call, the company states: “Da Vinci procedures grew 19%, led by continued strength in general surgery and gynecology. As adoption expands beyond urology, the lower growth…
Intuitive Surgical names new Chief Medical Officer
In the conference call, the company states: “Doctor Myriam Curet is retiring this quarter after more than 20 years as Intuitive’s Chief Medical Officer. I’d like to thank Myriam for…
Intuitive Surgical says ‘remain cautious’ on impact of subsidies under ACA
The company states: “With respect to the exploration of subsidies for enhanced premiums under ACA. While we did not see any significant impact on procedure volumes in Q1, at this…
Intuitive Surgical reverses post-earnings gains, falls 2% afterhours to $440
16:52 EDT Intuitive Surgical (ISRG) reverses post-earnings gains, falls 2% afterhours to $440
Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today...
Intuitive Surgical Earnings Call Transcript: Q1 2026
Q1 delivered 17% procedure growth and 23% revenue growth, with strong U.S. and European performance and robust adoption of da Vinci 5, Ion, and SP platforms. Guidance for 2026 was raised, and innovation-led revenue growth outpaced procedures, supported by digital and AI investments.
Intuitive Surgical reports Q1 adjusted EPS $2.50, consensus $2.11
Reports Q1 revenue $2.77B, consensus $2.62B. Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%...
Intuitive Surgical sees FY26 non-GAAP gross profit margin 67.5%-68.5% of revenue
The company expects the following results for the full year of 2026: Worldwide da Vinci procedure growth of approximately 13.5% to 15.5% in 2026. Non-GAAP gross profit margin to be…
Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Interactive Brokers (IBKR), consensus $6.60… Intuitive Surgical (ISRG), consensus $2.11… Capital One (COF), consens...
Intuitive Surgical options imply 6.6% move in share price post-earnings
Pre-earnings options volume in Intuitive Surgical (ISRG) is 2.7x normal with calls leading puts 4:3. Implied volatility suggests the market is anticipating a move near 6.6%, or $29.90, after results…
Options Volatility and Implied Earnings Moves Today, April 21, 2026
Today, several major companies are expected to report earnings: 3M (MMM), Annaly Capital (NLY), Danaher (DHR), GE Aerospace (GE), Halliburton (HAL), Intuitive Surgical (ISRG), Northrop Grumman (NOC), ...
SurGenTec Secures FDA 510(k) Clearance for TiLink™ SI joint fusion- Now Navigation Compatible
BOCA RATON, Fla.--(BUSINESS WIRE)---- $ISRG #FDAcleared--SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has ...
Wall Street Is On Sale. Buy Or Wait?
Holiday shoppers look for “For Sale” signs, while those shopping during Thanksgiving seek out bargains. In retail, a reduction in price is an invitation to act.
Intuitive Expands Investment and Footprint in Europe
Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated ...
More Upside For ISRG Stock?
Intuitive Surgical reported strong Q4 2025 outcomes with adjusted EPS of $2.53, exceeding estimates of $2.26 and increasing by 14.5% from Q4 2024's $2.21. Revenue reached $2.87 billion, a 19% increase...
20 Million Patients Benefit from da Vinci Surgery Globally
Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies Achievement reflects the dedication of...